skip to main content

Chemistry 250 Course: Advances in Pharmaceutical Research

Tuesday, April 26, 2016
4:00pm to 5:00pm
Add to Cal
Noyes 153 (J. Holmes Sturdivant Lecture Hall)
Discovery and Development of Halaven, a Fully Synthetic Macrocyclic Ketone Analog of Halichondrin B, for the Treatment of Late-Stage Breast Cancer and Soft-Tissue Sarcoma
Frank Fang, Dr., Ph.D., Vice-President, Process Research & Development, Eisai, Inc.,
For more information, please contact Lynne Martinez by phone at 626-395-4004 or by email at [email protected].